Search Results - "Petersson, F."

Population‐based estimates of common comorbidities and cardiovascular disease in ankylosing spondylitis by Bremander, Ann, Petersson, Ingemar F., Bergman, Stefan, Englund, Martin

“…Objective To study the rate of common comorbidities and cardiovascular disease in patients with ankylosing spondylitis (AS) compared with the general…”
Get full text

High and rising burden of hip and knee osteoarthritis in the Nordic region, 1990–2015: Findings from the Global Burden of Disease Study 2015 by Kiadaliri, Aliasghar A, Lohmander, L Stefan, Moradi-Lakeh, Maziar, Petersson, Ingemar F, Englund, Martin

“…Background and purpose — Osteoarthritis (OA) imposes a substantial burden on individuals and societies. We report on the burden of knee and hip OA in the…”
Get full text

Muscle strength in adolescent men and risk of cardiovascular disease events and mortality in middle age: a prospective cohort study by Timpka, Simon, Petersson, Ingemar F, Zhou, Caddie, Englund, Martin

“…Ischemic heart disease and stroke are two severe types of cardiovascular disease (CVD), a major contributor to the global burden of disease. The preventive…”
Get full text

Pretreatment multi-biomarker disease activity score and radiographic progression in early RA: results from the SWEFOT trial by Hambardzumyan, Karen, Bolce, Rebecca, Saevarsdottir, Saedis, Cruickshank, Scott E, Sasso, Eric H, Chernoff, David, Forslind, Kristina, Petersson, Ingemar F, Geborek, Pierre, van Vollenhoven, Ronald F

“…Prediction of radiographic progression (RP) in early rheumatoid arthritis (eRA) would be very useful for optimal choice among available therapies. We evaluated…”
Get more information

Validity of diagnostic codes and prevalence of physician-diagnosed psoriasis and psoriatic arthritis in southern Sweden--a population-based register study by Löfvendahl, Sofia, Theander, Elke, Svensson, Åke, Carlsson, Katarina Steen, Englund, Martin, Petersson, Ingemar F

“…To validate diagnostic codes for psoriasis and psoriatic arthritis (PsA) and estimate physician-diagnosed prevalence of psoriasis and PsA in the Skåne region,…”
Get full text

Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial by van Vollenhoven, RF, Dr, Ernestam, S, MD, Geborek, P, MD, Petersson, IF, MD, Cöster, L, MD, Waltbrand, E, MD, Zickert, A, MD, Theander, J, MD, Thörner, Å, MD, Hellström, H, MD, Teleman, A, MD, Dackhammar, C, MD, Akre, F, MD, Forslind, K, MD, Ljung, L, MD, Oding, R, MD, Chatzidionysiou, A, MD, Wörnert, M, RN, Bratt, J, MD

“…Summary Background New treatment strategies for early rheumatoid arthritis are evolving rapidly. We aimed to compare addition of conventional disease-modifying…”
Get full text

Conventional combination treatment versus biological treatment in methotrexate-refractory early rheumatoid arthritis: 2 year follow-up of the randomised, non-blinded, parallel-group Swefot trial by van Vollenhoven, Ronald F, Prof, Geborek, Pierre, MD, Forslind, Kristina, MD, Albertsson, Kristina, MD, Ernestam, Sofia, MD, Petersson, Ingemar F, MD, Chatzidionysiou, Katerina, MD, Bratt, Johan, MD

“…Summary Background Analysis of the Swedish Farmacotherapy (Swefot) trial at 12 months showed that the addition of an anti-tumour-necrosis-factor agent gave an…”
Get full text

Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis by JACOBSSON, Lennart T. H, TURESSON, Carl, GÜLFE, Anders, KAPETANOVIC, Meliha C, PETERSSON, Ingemar F, SAXNE, Tore, GEBOREK, Pierre

“…OBJECTIVE: To investigate the risk of cardiovascular disease (CVD) in patients with rheumatoid arthritis (RA) treated with tumor necrosis factor (TNF)…”
Get full text

Comparison of non-radiographic axial spondyloarthritis and ankylosing spondylitis patients--baseline characteristics, treatment adherence, and development of clinical variables during three years of anti-TNF therapy in clinical practice by Wallman, Johan K, Kapetanovic, Meliha C, Petersson, Ingemar F, Geborek, Pierre, Kristensen, Lars Erik

“…The relationship between non-radiographic axial spondyloarthritis (nr-axSpA) and ankylosing spondylitis (AS) is currently debated. Using observational data…”
Get full text

Solitary plexiform neurofibroma of the tongue: report of a case with no evidence of neurofibromatosis type 1 by Zhang, Y., Chen, M.W.J., Petersson, F., Lim, A.A.T.

“…Neurofibromas are frequently present in the skin, but are uncommon in the oral and maxillofacial region. There are three histological variants of neurofibroma:…”
Get full text

Legal Minors Who Inject: Differences in Socio-Demographics and Treatment Needs Compared to Adults in a Swedish National Sample of People with Injecting Drug Use by Turner, R., Barrett, D., Petersson, F., Kåberg, M.

“…Injection drug use among legal minors is under-researched. Although the population may be small in absolute terms, treatment needs may be greater than for…”
Get full text

Chronic musculoskeletal pain, prevalence rates, and sociodemographic associations in a Swedish population study by BERGMAN, Stefan, HERRSTRÖM, Per, HÖGSTRÖM, Kristina, PETERSSON, Ingemar F, SVENSSON, Björn, JACOBSSON, Lennart T. H

“…OBJECTIVE: To estimate the prevalence of chronic regional and widespread musculoskeletal pain in a sample of the general adult population and study the…”
Get full text

The nature stroke study; NASTRU: A randomized controlled trial of nature-based post-stroke fatigue rehabilitation by Pálsdóttir, Anna María, Stigmar, Kjerstin, Norrving, Bo, Petersson, Ingemar F, Åström, Mikael, Pessah-Rasmussen, Hélène

“…To determine whether nature-based rehabilitation, as an add-on to standard care, has a long-term influence on post-stroke fatigue, perceived value of everyday…”
Get full text

Predictors of work disability during the first 3 years after diagnosis in a national rheumatoid arthritis inception cohort by Olofsson, Tor, Petersson, Ingemar F, Eriksson, Jonas K, Englund, Martin, Simard, Julia F, Nilsson, Jan-Åke, Geborek, Pierre, Jacobsson, Lennart T H, Askling, Johan, Neovius, Martin

“…To identify predictors of sick leave and disability pension in patients with early rheumatoid arthritis (RA). Individuals aged 19-59 years diagnosed with early…”
Get more information

Sick leave in Sweden before and after total joint replacement in hip and knee osteoarthritis patients by Stigmar, Kjerstin, Dahlberg, Leif E, Zhou, Caddie, Jacobson Lidgren, Helena, Petersson, Ingemar F, Englund, Martin

“…Background and purpose - Little is know about patterns of sick leave in connection with total hip and knee joint replacement (THR and TKR) in patients with…”
Get full text

Health care utilization among individuals who die by suicide as compared to the general population: a population-based register study in Sweden by Bondesson, Elisabeth, Alpar, Tori, Petersson, Ingemar F, Schelin, Maria E. C, Jöud, Anna

“…Abstract Background Globally, 700 000 people die every year by suicide. Health care consultation patterns the period before suicide could be one potential way…”
Get full text

Prevalence of spondyloarthritis and its subtypes in southern Sweden by Haglund, E, Bremander, A B, Petersson, I F, Strömbeck, B, Bergman, S, Jacobsson, L T H, Turkiewicz, A, Geborek, P, Englund, M

“…To estimate the prevalence of spondyloarthritis and its subtypes. The Swedish healthcare organisation comprises a system where all inpatient and outpatient…”
Get more information

Educational inequalities in mortality associated with rheumatoid arthritis and other musculoskeletal disorders in Sweden by Kiadaliri, Aliasghar A, Petersson, Ingemar F, Englund, Martin

“…Musculoskeletal (MSK) disorders are less likely to be reported as an underlying cause of death (UCD) and since cause of death studies are generally limited to…”
Get full text

Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas by Geborek, P, Bladström, A, Turesson, C, Gulfe, A, Petersson, I F, Saxne, T, Olsson, H, Jacobsson, L T H

“…Objective: To determine whether TNF blockers increase tumour risk in patients with RA. Material and methods: The South Swedish Arthritis Treatment Group…”
Get full text

Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial by Kastbom, Alf, Forslind, Kristina, Ernestam, Sofia, Geborek, Pierre, Karlsson, Johan A, Petersson, Ingemar F, Saevarsdottir, Saedis, Klareskog, Lars, van Vollenhoven, Ronald F, Lundberg, Karin

“…To determine the relationship between changes in antibody levels towards citrullinated peptides derived from different candidate autoantigens and therapeutic…”
Get more information